Related Experiment Videos
Cyclooxygenase, NSAIDs, and colorectal cancer
1Department of Medicine, Veterans Affairs Medical Center, Nastiville, TN, USA.
Abstract:
Prevention of human diseases has become a major focus of biomedical investigators around the world. Our current screening and treatment regimens for colorectal cancer are not effective, as indicated by the fact that this disease is the second leading cause of death from cancer in the United States. Recently published reports indicate that continuous use of aspirin reduces the relative risk of colorectal cancer by about 50%. Other work demonstrates that NSAIDs cause regression of adenomas in patients with familial adenomatous polyposis and prevent the development of colon tumors in carcinogen-treated animals. This review is a summary of the literature and includes an analysis of recent reports indicating the potential molecular basis for the chemoprotective effects of NSAIDs.
Insights
Continuous use of aspirin and NSAIDs significantly lowers colorectal cancer risk by approximately 50%. These drugs may prevent colon tumor development and regress adenomas, offering potential chemoprotective benefits.
Area of Science:
- Biomedical research
- Cancer prevention
- Gastroenterology
Background:
- Colorectal cancer is a leading cause of cancer death in the U.S.
- Current screening and treatment methods are insufficient.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) show promise in cancer prevention.
Purpose of the Study:
- To review and analyze the chemoprotective effects of NSAIDs against colorectal cancer.
- To explore the potential molecular mechanisms behind NSAID efficacy.
- To summarize recent findings on NSAID use for cancer prevention.
Main Methods:
- Literature review and analysis of published reports.
- Examination of studies on aspirin and NSAID use in colorectal cancer.
- Investigation of animal models and human patient data.
Main Results:
- Continuous aspirin use is associated with a ~50% reduction in colorectal cancer risk.
- NSAIDs promote adenoma regression in familial adenomatous polyposis patients.
- NSAIDs prevent colon tumor formation in animal models.
Conclusions:
- NSAIDs, including aspirin, demonstrate significant chemopreventive potential against colorectal cancer.
- Understanding the molecular basis of NSAID action is crucial for developing targeted prevention strategies.
- Further research into NSAID mechanisms could lead to improved colorectal cancer prevention regimens.